《中国老年糖尿病诊疗指南(2024版)》指导下老年糖尿病的诊治重点与策略革新

任洁; 鹿斌

doi:10.16766/j.cnki.issn.1674-4152.004237

《中国老年糖尿病诊疗指南(2024版)》指导下老年糖尿病的诊治重点与策略革新

doi: 10.16766/j.cnki.issn.1674-4152.004237

任洁,
鹿斌^,

复旦大学附属华东医院内分泌科，上海 200040

基金项目:

上海市卫健委卫生健康学科带头人项目 2022XD020

国家科技重大专项子课题 2024ZD0523206

详细信息

通讯作者:
鹿斌，E-mail: doctor_lubinfudan@126.com

中图分类号: R587.1
计量
- 文章访问数: 13
- HTML全文浏览量: 12
- PDF下载量: 0
- 被引次数: 0
出版历程
- 收稿日期: 2025-03-26
- 网络出版日期: 2026-01-07

Innovation of diagnosis and treatment priorities and strategies under the guidance of Chinese Guidelines for the Diagnosis and Treatment of Diabetes in the Elderly (2024 Edition)

REN Jie,
LU Bin^,

Department of Endocrinology, Huadong Hospital Affiliated to Fudan University, Shanghai 200040, China

摘要

摘要: 随着我国人口老龄化进程的加速，糖尿病的患病率持续攀升，已成为严重威胁老年人健康的重要公共卫生问题。老年糖尿病患者具有异质性大、共病多、并发症风险高、管理难度大等特点，给临床诊治带来了更大的挑战。老年糖尿病患者的身体机能和代谢状态与年轻患者存在显著差异，这使得他们在疾病的发生、发展和治疗过程中表现出独特的特点。因此，《中国老年糖尿病诊疗指南(2024版)》(以下简称《新版指南》)应运而生，对老年糖尿病的特殊性、诊断、防治、并发症及共患疾病管理等方面进行了系统阐述，并提出了许多创新性观点。《新版指南》强调了老年糖尿病患者的个体化治疗原则，指出治疗方案应综合考虑患者的年龄、身体状况、并发症情况以及个人意愿等因素，以实现最佳的治疗效果。同时，《新版指南》还特别关注了老年糖尿病患者的营养管理、运动指导以及心理健康等方面，提出了全面的综合管理策略。本文结合《新版指南》与我国老年糖尿病诊治的发展历程、研究现况进行分析，提出老年糖尿病的诊治重点和改进策略。关注老年糖尿病患者的长期随访和管理，通过多学科团队合作，实现患者的规范化综合管理，以期能够更好地指导和帮助临床医生实现老年糖尿病患者的规范化综合管理，改善中国老年糖尿病患者的临床结局。
- 老年糖尿病 /
- 诊治现状 /
- 综合管理
Abstract: With the acceleration of population aging in China, the prevalence of diabetes continues to rise and has become a significant public health issue threatening the health of the elderly. Patients with geriatric diabetes are characterized by high heterogeneity, multiple comorbidities, high risk of complications, and great difficulty in management, which pose greater challenges to clinical diagnosis and treatment. The physiological functions and metabolic status of elderly patients with diabetes show significant differences compared with younger patients, resulting in unique features in the occurrence, progression, and treatment of the disease. Therefore, Chinese Guidelines for the Diagnosis and Treatment of Diabetes in the Elderly (2024 Edition) (hereinafter referred to as the "New Guidelines") have been developed. The "New Guidelines" systematically elaborate on the particularities of geriatric diabetes, diagnosis, prevention and treatment, complications, and management of comorbidities, and propose many innovative views. The "New Guidelines" emphasize the principle of individualized treatment for elderly patients with diabetes, pointing out that treatment plans should take into account factors such as the patient's age, physical condition, complications, and personal preferences to achieve the best therapeutic effect. Meanwhile, the "New Guidelines" also pay special attention to the nutritional management, exercise guidance, and mental health of elderly patients with diabetes, proposing a comprehensive integrated management strategy. This paper will review the development process and current research status of geriatric diabetes diagnosis and treatment in China in combination with the "New Guidelines", and propose the key points and improvement strategies for the diagnosis and treatment of geriatric diabetes. In addition, we will focus on the long-term follow-up and management of elderly patients with diabetes and propose how to achieve standardized comprehensive management of patients through multidisciplinary team cooperation, in order to better guide and help clinicians to achieve standardized comprehensive management of elderly patients with diabetes and improve the clinical outcomes of Chinese elderly patients with diabetes.
- Geriatric diabetes /
- Current diagnosis and treatment status /
- Comprehensive management

HTML全文

参考文献(39)

[1]	LI Y Z, TENG D, SHI X G, et al. Prevalence of diabetes recorded in China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study[J]. BMJ, 2020, 369: m997. DOI: 10.1136/bmj.m997.
[2]	DU Q H, YANG J H, ZHANG Z C, et al. Exploring the decision-making experience of elderly diabetes patients regarding their health-seeking behaviour: a descriptive qualitative study[J]. BMJ Open, 2024, 14(10): e087126. DOI: 10.1136/bmjopen-2024-087126.
[3]	TANG O, MATSUSHITA K, CORESH J, et al. Mortality implications of prediabetes and diabetes in older adults[J]. Diabetes Care, 2020, 43(2): 382-388. doi: 10.2337/dc19-1221
[4]	DOUCET J, GOURDY P, MEYER L, et al. Management of glucose-lowering therapy in older adults with type 2 diabetes: challenges and opportunities[J]. Clin Interv Aging, 2023, 18: 1687-1703. doi: 10.2147/CIA.S423122
[5]	UMEGAKI H. Management of older adults with diabetes mellitus: perspective from geriatric medicine[J]. J Diabetes Investig, 2024, 15(10): 1347-1354. doi: 10.1111/jdi.14283
[6]	国家老年医学中心, 中华医学会老年医学分会, 中国老年保健协会糖尿病专业委员会. 中国老年糖尿病诊疗指南(2024版)[J]. 中华糖尿病杂志, 2024, 16(2): 147-189. Center for Geriatric Medicine, Chinese Medical Association Geriatric Branch, Chinese Association of Geriatric Health Care Diabetes Committee. Chinese Geriatric Diabetes Diagnosis and Treatment Guidelines (2024 Edition)[J]. Chinese Journal of Diabetes Mellitus, 2024, 16(2): 147-189.
[7]	YUN J S, KIM K, AHN Y B, et al. Holistic and personalized strategies for managing in elderly type 2 diabetes patients[J]. Diabetes Metab J, 2024, 48(4): 531-545. doi: 10.4093/dmj.2024.0310
[8]	SALOM VENDRELL C, GARCIA TERCERO E, MORO HERNANDEZ J B, et al. Sarcopenia as a little-recognized comorbidity of type Ⅱ diabetes mellitus: a review of the diagnosis and treatment[J]. Nutrients, 2023, 15(19): 1-15.
[9]	BELLARY S, KYROU I, BROWN J E, et al. Type 2 diabetes mellitus in older adults: clinical considerations and management[J]. Nat Rev Endocrinol, 2021, 17(9): 534-548. doi: 10.1038/s41574-021-00512-2
[10]	WANG Y, LI R, YUAN L, et al. Association between diabetes complicated with comorbidities and frailty in older adults: a cross-sectional study[J]. J Clin Nurs, 2023, 32(5-6): 894-900. doi: 10.1111/jocn.16442
[11]	NISHIMURA A, MASUDA C, MURAUCHI C, et al. Relationship between frailty and diabetic pharmacologic therapy in older adults with type 2 diabetes: a cross-sectional study[J]. Drugs Aging, 2024, 41(6): 531-542. doi: 10.1007/s40266-024-01119-8
[12]	RASHIDI M, YILDIRIM G, KARAMAN F, et al. Determination of the relationship between frailty level and quality of life in elderly individuals with type 2 diabetes[J]. Sci Rep, 2024, 14(1): 32028. DOI: 10.1038/s41598-024-83766-w.
[13]	DENG L F, LUO S T, WANG T Y, et al. Depression screening model for middle-aged and elderly diabetic patients in China[J]. Sci Rep, 2024, 14(1): 29158. DOI: 10.1038/s41598-024-80816-1.
[14]	CHEN L K, CHEN Y M, LIN M H, et al. Care of elderly patients with diabetes mellitus: a focus on frailty[J]. Ageing Res Rev, 2010, 9 Suppl 1: S18-S22.
[15]	BILAL A, PRATLEY R E. Newer glucose-lowering therapies in older adults with type 2 diabetes[J]. Endocrinol Metab Clin North Am, 2023, 52(2): 355-375. doi: 10.1016/j.ecl.2022.10.010
[16]	American Diabetes Association Professional Practice Committee. 13. older adults: standards of care in diabetes-2025[J]. Diabetes Care, 2025, 48(1 Suppl 1): S266-S282.
[17]	PRATLEY R E, KANAPKA L G, RICKELS M R, et al. Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a randomized clinical trial[J]. JAMA, 2020, 323(23): 2397-2406. doi: 10.1001/jama.2020.6928
[18]	倪青, 卜祥伟. 老年糖尿病中医诊疗指南[J]. 中华全科医学, 2024, 22(8): 1272-1278. NI Q, BU X W. Guidelines for Traditional Chinese Medicine Diagnosis and Treatment of Geriatric Diabetes[J]. Chinese Journal of General Practice, 2024, 22(8): 1272-1278.
[19]	KIM K, KIM B, LEE K, et al. Older adults with diabetes in Korea: latest clinical and epidemiologic trends[J]. Diabetes Metab J, 2025, 49(2): 183-193. doi: 10.4093/dmj.2024.0836
[20]	WANG W X, KONG L N, ZENG L, et al. Exercise interventions for frail older adults with diabetes: a scoping review[J]. Geriatr Nurs, 2024, 58: 200-207. doi: 10.1016/j.gerinurse.2024.05.030
[21]	LIU Y, WANG X X, REN X W, et al. Association of physical activity and dietary diversity with cognitive function in the elderly with type 2 diabetes mellitus: findings from a cross-sectional study[J]. J Am Nutr Assoc, 2025, 44(2): 104-114.
[22]	RICHARDSON K M, SCHEMBRE S M, DA SILVA V, et al. Adding a brief continuous glucose monitoring intervention to the National Diabetes Prevention Program: a multimethod feasibility study[J]. J Diabetes Res, 2024, 2024: 7687694. DOI: 10.1155/2024/7687694.
[23]	FLOREZ J C. Advancing precision medicine in type 2 diabetes[J]. Lancet Diabetes Endocrinol, 2024, 12(2): 87-88. doi: 10.1016/S2213-8587(23)00384-4
[24]	中国医师协会内分泌代谢科医师分会, 国家代谢性疾病临床医学研究中心. 糖尿病分型诊断中国专家共识[J]. 中华糖尿病杂志, 2022, 14(2): 120-139. Chinese Medical Doctor Association Endocrinology and Metabolism Branch, National Clinical Research Center for Metabolic Diseases (Changsha). Chinese Expert Consensus on the classification and diagnosis of diabetes[J]. Chinese Journal of Diabetes Mellitus, 2022, 14(2): 120-139.
[25]	SOKOLOWSKI E K, KURSAWE R, SELVAM V, et al. Multi-omic human pancreatic islet endoplasmic reticulum and cytokine stress response mapping provides type 2 diabetes genetic insights[J]. Cell Metab, 2024, 36(11): 2468-2488. doi: 10.1016/j.cmet.2024.09.006
[26]	JIA W P, CHAN J C, WONG T Y, et al. Diabetes in China: epidemiology, pathophysiology and multi-omics[J]. Nat Metab, 2025, 7(1): 16-34. doi: 10.1038/s42255-024-01190-w
[27]	CHAN J C N, LIM L L, WAREHAM N J, et al. The Lancet Commission on diabetes: using data to transform diabetes care and patient lives[J]. Lancet, 2021, 396(10267): 2019-2082.
[28]	TOBIAS D K, MERINO J, AHMAD A, et al. Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine[J]. Nat Med, 2023, 29(10): 2438-2457. doi: 10.1038/s41591-023-02502-5
[29]	CARRASCO-ZANINI J, PIETZNER M, WHEELER E, et al. Multi-omic prediction of incident type 2 diabetes[J]. Diabetologia, 2024, 67(1): 102-112. doi: 10.1007/s00125-023-06027-x
[30]	朱文奎, 刘炜, 徐群, 等. MemTrax在线工具在社区老年糖尿病认知功能筛查中的应用价值[J]. 中华全科医学, 2023, 21(12): 2089-2092. ZHU W K, LIU W, XU Q, et al. Application value of the MemTrax Online Tool in cognitive function screening of elderly patients with diabetes in the community[J]. Chinese Journal of General Practice, 2023, 21(12): 2089-2092.
[31]	RAVAUT M, HARISH V, SADEGHI H, et al. Development and validation of a machine learning model using administrative health data to predict onset of type 2 diabetes[J]. JAMA Netw Open, 2021, 4(5): e2111315. DOI: 10.1001/jamanetworkopen.2021.11315.
[32]	SCHÖN M, PRYSTUPA K, MORI T, et al. Analysis of type 2 diabetes heterogeneity with a tree-like representation: insights from the prospective German Diabetes Study and the LURIC cohort[J]. Lancet Diabetes Endocrinol, 2024, 12(2): 119-131. doi: 10.1016/S2213-8587(23)00329-7
[33]	NOMURA A, NOGUCHI M, KOMETANI M, et al. Artificial Intelligence in current diabetes management and prediction[J]. Curr Diab Rep, 2021, 21(12): 61. DOI: 10.1007/s11892-021-01423-2.
[34]	RAJESH A E, DAVIDSON O Q, LEE C S, et al. Artificial intelligence and diabetic retinopathy: AI framework, prospective studies, head-to-head validation, and cost-effectiveness[J]. Diabetes Care, 2023, 46(10): 1728-1739. doi: 10.2337/dci23-0032
[35]	GUAN Z Y, LI H T, LIU R H, et al. Artificial intelligence in diabetes management: advancements, opportunities, and challenges[J]. Cell Rep Med, 2023, 4(10): 101213. DOI: 10.1016/j.xcrm.2023.101213.
[36]	SOWAH R A, BAMPOE-ADDO A A, ARMOO S K, et al. Design and development of diabetes management system using machine learning[J]. Int J Telemed Appl, 2020, 2020: 8870141. DOI: 10.1155/2020/8870141.
[37]	AMERZADEH M, KISOMI Z S, SENMAR M, et al. Author Correction: self-care behaviors, medication adherence status, and associated factors among elderly individuals with type 2 diabetes[J]. Sci Rep, 2024, 14(1): 23039. DOI: 10.1038/s41598-024-74248-0.
[38]	ZAN H J, MENG Z X, LI J, et al. Factors associated with quality of life among elderly patients with type 2 diabetes mellitus: the role of family caregivers[J]. BMC Public Health, 2024, 24(1): 539. DOI: 10.1186/s12889-024-17917-z.
[39]	王俊薇, 刘云, 李连喜. 中国糖尿病管理模式及思考[J]. 中国全科医学, 2021, 24(24): 3019-3025. WANG J W, LIU Y, LI L X. Management modes and considerations of diabetes in China[J]. Chinese General Practice, 2021, 24(24): 3019-3025.